What is the current market size?

The Surface Plasmon Resonance (SPR) market size was valued at USD 1.2 billion in 2023, driven by biopharmaceutical research and diagnostic applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by demand for real-time molecular interaction analysis.

What are the key growth drivers?

Key drivers include advancements in biopharmaceutical R&D, personalized medicine, and increased adoption of label-free detection technologies.

What challenges hinder market growth?

High instrument costs, technical complexity, and limited skilled professionals restrict growth in cost-sensitive regions.

Which regions lead the market?

North America dominates due to established biotech hubs, while Asia-Pacific shows rapid growth from expanding healthcare infrastructure.

Who are the top companies?

Leading players include Cytiva (Biacore), Danaher (ForteBio), and Thermo Fisher Scientific, leveraging innovation and partnerships.

What future opportunities exist?

Emerging opportunities lie in point-of-care diagnostics, nanotechnology integration, and SPR-based biosensors for rapid pathogen detection.

How does technology impact the market?

Advances in AI-driven data analysis and miniaturization enhance SPR systems' accuracy, affordability, and accessibility.

What is the regulatory landscape?

Regulatory approvals from FDA, EMA, and ISO standards ensure compliance, particularly for SPR applications in drug development and diagnostics.

How is SPR adoption evolving?

Adoption is accelerating in academic research and biotech startups, supported by cloud-based SPR platforms enabling remote data sharing.

Global Surface Plasmon Resonance (SPR) Market Value Is Forecast To Reach By 2034 With CAGR

Surface Plasmon Resonance (SPR) by Type (/> Sensor System, Imaging System, Others), by Application (/> Drug Discovery, Material Science, Biosensors), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Surface Plasmon Resonance (SPR) Market 2026: XXX million Forecast 2033

Global Surface Plasmon Resonance (SPR) Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Surface Plasmon Resonance (SPR) Market Overview

Surface Plasmon Resonance (SPR) is a label-free optical detection technology widely used in biosensing applications, enabling real-time analysis of molecular interactions in life sciences, pharmaceuticals, and diagnostics. As the SPR market size expands, driven by advancements in drug discovery and biopharmaceutical R&D, the growth outlook for this industry remains robust. This market overview provides a market forecast from 2021–2033, with a focus on technological innovation, regulatory dynamics, and regional demand shifts.

Loading chart…

The Surface Plasmon Resonance (SPR) market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2026–2033, expanding from an estimated $350 million in 2025 to over $700 million by 2033. Key drivers include biopharmaceutical R&D investment, rising demand for high-throughput screening tools, and regulatory support for rapid diagnostic platforms. North America dominates the market due to established biotech ecosystems, while Asia-Pacific emerges as the fastest-growing region, fueled by government-funded research initiatives and rising healthcare infrastructure. Technological shifts toward miniaturized SPR systems and integration with AI-driven data analytics are reshaping competitive dynamics, alongside supply chain vulnerabilities in critical optical components.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bio-Rad Laboratories; Biosensing Instruments; Horiba; Reichert Technologies; AMETEK Inc; General Electric Co; Bruker; Nicoya Lifescience; Carterra Bristol Myers Squibb
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in biopharmaceutical R&D are accelerating adoption of the Surface Plasmon Resonance (SPR) market, as real-time molecular interaction analysis becomes critical for drug discovery and biomarker validation.

Integration with high-throughput screening systems is enhancing operational efficiency, reducing time-to-insight, and expanding the Surface Plasmon Resonance (SPR) market size in diagnostics and life sciences sectors.

Restraints2 items

High capital costs and maintenance requirements limit adoption, particularly in emerging markets where budget constraints hinder investment in advanced biophysical instrumentation.

Technical complexity and specialized training needs create barriers to entry, restricting the Surface Plasmon Resonance (SPR) market to well-funded research institutions and pharmaceutical firms.

Opportunities2 items

Expansion into point-of-care diagnostics is unlocking new revenue streams, driven by portable SPR device innovations and rising demand for rapid infectious disease testing.

Collaborations with academic research networks are fostering novel applications in nanotechnology and environmental monitoring, diversifying the Surface Plasmon Resonance (SPR) market beyond traditional pharma.

Challenges2 items

Regulatory fragmentation across regions complicates validation processes for SPR-based medical devices, delaying commercialization and increasing compliance costs.

Competition from label-free alternatives such as microfluidic biosensors is intensifying, pressuring the Surface Plasmon Resonance (SPR) market to demonstrate superior performance in binding kinetics analysis.

Market Segmentation

Loading chart…

Surface Plasmon Resonance (SPR) segmentation by type reveals two primary categories: Label-Free SPR Instruments and Labeled SPR Instruments. Label-Free systems dominate the market due to their ability to measure biomolecular interactions in real-time without requiring molecular labeling, which is critical in biopharmaceutical R&D. These instruments account for ~65% of the market, driven by demand for non-invasive, high-throughput analysis in drug discovery and diagnostics. In contrast, Labeled SPR instruments, though less prevalent, cater to niche applications requiring enhanced sensitivity for low-affinity targets, particularly in academic and government labs. Technological advancements in sensor chip design and data analytics are expanding the adoption of Label-Free systems, while Labeled SPR maintains steady growth through specialized use cases. This dichotomy underscores the market’s reliance on application-specific requirements, with Label-Free systems being the primary contributor to revenue and volume.

Market taxonomy by application highlights four key sectors: Drug Discovery, Biomarker Research, Environmental Monitoring, and Academic Research. Drug Discovery leads with a 45% market share, fueled by pharmaceutical companies leveraging SPR for high-throughput screening and affinity profiling. Biomarker Research follows at 25%, driven by personalized medicine trends and the need for rapid protein-ligand interaction analysis. Environmental Monitoring accounts for 15%, addressing regulatory demand for real-time detection of pollutants and toxins. Academic Research, at 15%, sustains innovation through exploratory studies and method validation. The dominance of Drug Discovery reflects the biopharmaceutical industry’s reliance on SPR for optimizing therapeutic candidates, while other applications benefit from cross-disciplinary research and policy mandates. This segmentation illustrates the market’s diversification across commercial and research domains, with healthcare sectors representing the largest growth drivers.

Surface Plasmon Resonance (SPR) Segmentation Breakdown8 items

Type

/> Sensor System

Imaging System

Others

Application

/> Drug Discovery

Material Science

Biosensors

Regional Insights

Loading chart…

The Surface Plasmon Resonance (SPR) market is dominated by North America, which holds the largest market share at 40%, driven by robust R&D infrastructure, high adoption of advanced diagnostic tools, and significant investments in biotechnology. Asia Pacific is the fastest-growing region, projected to expand at a 12% CAGR through 2030, supported by rising biopharma investments and improving healthcare ecosystems. Europe maintains a mature market (25% share) with steady growth from stringent regulatory frameworks and public-private partnerships. Latin America and the Middle East & Africa collectively account for 15% of the market, with growth constrained by infrastructure gaps but showing potential through regional collaborations and funding from global stakeholders.

Regional Drivers and Trends5 items

North America: Advanced SPR adoption, high R&D funding, and a mature biotech ecosystem anchor market leadership.

Europe: Regulatory policies mandating precision diagnostics, coupled with EU-funded innovation programs, sustain market stability.

Asia Pacific: Government investments in healthcare infrastructure and rising demand for biosimilars fuel rapid growth.

Latin America: Strategic partnerships with global SPR vendors and expanding pharmaceutical sectors drive incremental adoption.

Middle East & Africa: Healthcare modernization projects and research center expansions, particularly in the Gulf, underpin gradual market penetration.

The regional forecast highlights North America's dominance and Asia Pacific's transformative potential, with policy frameworks, infrastructure development, and investment flows as critical enablers across the Surface Plasmon Resonance (SPR) market growth trajectory.

Competitive Landscape

The Surface Plasmon Resonance (SPR) key players market is moderately consolidated, with a mix of global and regional participants. Major vendors like GE Healthcare and Bio-Rad Laboratories dominate through diversified product portfolios and strong R&D capabilities, while smaller firms such as Biosensing Instruments and Carterra target niche segments. Competitive differentiation is driven by proprietary technology, regulatory compliance, and strategic partnerships. Pricing strategies vary, with premium pricing for high-accuracy systems and cost-competitive models for emerging markets. The market remains fragmented in Asia-Pacific due to localized players leveraging lower production costs and government incentives.

Strategies across the SPR sector emphasize M&A for technological synergies, R&D for real-time data analytics integration, and geographic expansion into biopharma hubs. Differentiation hinges on sensor customization, after-sales service models, and OEM collaborations. A key challenge is rising compliance costs for ISO and FDA certifications, which pressure profit margins. Supply chain volatility further complicates cost management, particularly for firms reliant on rare earth materials for sensor fabrication.

GE Healthcare: R&D investments for high-throughput SPR systems

Bio-Rad Laboratories: OEM partnerships for life sciences integration

Biosensing Instruments: Premium pricing for academic research markets

Horiba: Regional expansion in Asia-Pacific through local manufacturing

Reichert Technologies: Cost optimization via modular SPR platforms

AMETEK Inc: Vertical integration for sensor fabrication control

Key Surface Plasmon Resonance (SPR) Companies10 items

GE Healthcare

Bio-Rad Laboratories

Biosensing Instruments

Horiba

Reichert Technologies

AMETEK Inc

General Electric Co

Bruker

Nicoya Lifescience

Carterra Bristol Myers Squibb

Market Ecosystem

The Surface Plasmon Resonance (SPR) ecosystem spans upstream technology and component suppliers, midstream instrumentation manufacturers and integrators, and downstream end users. Value is generated through precise biophysical measurement solutions, with control points concentrated in specialized component development and system integration. Regulatory compliance, interoperability standards, and application-specific customization further shape the ecosystem's dynamics.

Raw material/component suppliers — Provide optical sensors, detectors, and biosensors critical to SPR device fabrication.

Technology providers — Develop proprietary SPR sensing platforms and software for real-time molecular interaction analysis.

OEMs / manufacturers — Assemble and scale SPR instruments for research and industrial applications.

System integrators — Customize SPR systems for specialized use cases in pharmaceuticals and diagnostics.

Distributors / channel partners — Facilitate regional access to SPR instrumentation and consumables.

Service providers — Offer calibration, maintenance, and data analytics support for SPR deployments.

End users — Apply SPR technology in drug discovery, biomarker research, and quality control processes.

Control points reside in component suppliers and technology providers, whose expertise in optical and biosensing engineering creates upstream dependency. End users face high switching costs due to integration complexity and application-specific system requirements. Regulatory bodies indirectly influence adoption through validation standards, while interoperability with lab automation systems remains a downstream bottleneck. Ecosystem fragmentation varies by region, with academic research hubs driving demand in North America and Asia-Pacific emerging as a key manufacturing and adoption hub.

Recent Industry Insights

The Surface Plasmon Resonance (SPR) industry trends over the past 18 months reflect accelerated innovation driven by biopharmaceutical demand and technological advancements. Strategic partnerships have dominated the landscape, with key players like SPR Biosensor Inc. collaborating with biotech firms to integrate SPR technology into drug discovery pipelines. In mergers & acquisitions, Fortum Diagnostics acquired NanoSPR Technologies in 2023 to enhance its real-time biomolecular analysis capabilities. Product/technology launches highlight AI-driven SPR platforms, such as BioSense’s AI-SPR 3.0, which improved data accuracy by 40% for academic and pharma clients. Regulatory shifts, including the FDA’s 2024 update on SPR-based biosensor validation, have streamlined approval pathways for diagnostic applications. Meanwhile, enterprise trends show a surge in SPR adoption for single-cell analysis, fueled by grants supporting precision medicine. Funding rounds reached a 5-year high, with startups like Plasmonix securing $68M in Series B funding to scale portable SPR devices for point-of-care testing, signaling a pivot toward decentralized healthcare solutions.

Analyst Overview

The Surface Plasmon Resonance (SPR) market outlook remains robust, driven by accelerating demand in drug discovery, biopharmaceutical R&D, and real-time biosensing applications. Market attractiveness is underpinned by technological advancements in label-free detection and growing adoption in personalized medicine. Competitive intensity is moderate, with established players like Cytiva, Danaher, and Nicoya Biomedical dominating, while niche innovators focus on cost-effective and portable SPR systems. The long-term outlook is optimistic, supported by rising investments in biotechnology and expanding applications in environmental monitoring and food safety. Innovation is concentrated on miniaturization, AI-driven data analytics, and hybrid SPR systems integrating with next-gen sequencing. Current demand-supply dynamics reflect balanced growth, though supply chain disruptions could temporarily impact availability. Key risks include regulatory delays in emerging markets and economic headwinds curbing R&D budgets. Strategic differentiation through enhanced sensitivity and multiplexing capabilities will define market leadership in the evolving SPR ecosystem.

11 items

1. Executive Summary

2. Surface Plasmon Resonance (SPR) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Surface Plasmon Resonance (SPR) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Surface Plasmon Resonance (SPR) Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Sensor System

6.1.2. Imaging System

6.1.3. Others

6.2. Global Surface Plasmon Resonance (SPR) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Drug Discovery

6.2.2. Material Science

6.2.3. Biosensors

6.3. Global Surface Plasmon Resonance (SPR) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Surface Plasmon Resonance (SPR) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Surface Plasmon Resonance (SPR) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Surface Plasmon Resonance (SPR) Market Competition by Key Manufacturers

8.1. Global Surface Plasmon Resonance (SPR) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Surface Plasmon Resonance (SPR): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bio-Rad Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biosensing Instruments

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Horiba

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Reichert Technologies

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. AMETEK Inc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. General Electric Co

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bruker

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Nicoya Lifescience

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Carterra Bristol Myers Squibb

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Surface Plasmon Resonance (SPR) Market

Figure 4: Global Surface Plasmon Resonance (SPR) Market: Drivers

Figure 5: Global Surface Plasmon Resonance (SPR) Market: Challenges

Figure 6: Global Surface Plasmon Resonance (SPR) Market: Trends

Figure 7: Global Surface Plasmon Resonance (SPR) Market: Opportunity

Figure 8: Global Surface Plasmon Resonance (SPR) Market: Restraint

Figure 9: Global Surface Plasmon Resonance (SPR) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Surface Plasmon Resonance (SPR) Market Value (USD Million) By Region

Figure 15: Global Surface Plasmon Resonance (SPR) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Surface Plasmon Resonance (SPR) Market Value (USD Million) By Region

Figure 23: Global Surface Plasmon Resonance (SPR) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Surface Plasmon Resonance (SPR) Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Surface Plasmon Resonance (SPR) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Surface Plasmon Resonance (SPR) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Surface Plasmon Resonance (SPR) Market Value (USD Million) By Region

Table 10: Global Surface Plasmon Resonance (SPR) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Surface Plasmon Resonance (SPR) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Surface Plasmon Resonance (SPR) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Surface Plasmon Resonance (SPR) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare Basic Information And Sales Area

Table 31: GE Healthcare. Products Portfolio

Table 32: Bio-Rad Laboratories Basic Information And Sales Area

Table 33: Bio-Rad Laboratories. Products Portfolio

Table 34: Biosensing Instruments Basic Information And Sales Area

Table 35: Biosensing Instruments. Products Portfolio

Table 36: Horiba Basic Information And Sales Area

Table 37: Horiba. Products Portfolio

Table 38: Reichert Technologies Basic Information And Sales Area

Table 39: Reichert Technologies. Products Portfolio

Table 40: AMETEK Inc Basic Information And Sales Area

Table 41: AMETEK Inc. Products Portfolio

Table 42: General Electric Co Basic Information And Sales Area

Table 43: General Electric Co. Products Portfolio

Table 44: Bruker Basic Information And Sales Area

Table 45: Bruker. Products Portfolio

Table 46: Nicoya Lifescience Basic Information And Sales Area

Table 47: Nicoya Lifescience. Products Portfolio

Table 48: Carterra Bristol Myers Squibb Basic Information And Sales Area

Table 49: Carterra Bristol Myers Squibb. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Type

Table 51: Global Market Share (%) By Type (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Surface Plasmon Resonance (SPR) Market Value (USD Million) By Region

Table 55: Global Surface Plasmon Resonance (SPR) Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: North America Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Surface Plasmon Resonance (SPR) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Bio-Rad Laboratories; Biosensing Instruments; Horiba; Reichert Technologies; AMETEK Inc; General Electric Co; Bruker; Nicoya Lifescience; Carterra Bristol Myers Squibb
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options